US Stock
Closed Market
Alnylam Pharmaceuticals Stock
•ALNYClosed Market
$460,00
+$6,27(1,39%)Past Day
+$3,04(0,67%)After Hours
About Alnylam Pharmaceuticals
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. The company is headquartered in Cambridge, Massachusetts and currently employs 2,230 full-time employees. The company went IPO on 2004-05-28. The firm is engage Read moreSectorHealth Care
IndustryPharmaceuticals, Biotechnology & Life Sciences
ExchangeNASDAQ
Employees2,230
HeadquarterCambridge, United States
Websitealnylam.com
SymbolALNY
Key Statistics
General
Valuation Ratios
Profitability
Market Cap0
Dividend Yield$0
Avg. Volume0
Earnings per Share$0
Enterprise Value (EV)$0
52w High$0 (Invalid Date)
52w Low$0 (Invalid Date)
1Y Drawdown0%
EBITDA$0
PEG Ratio0,00
People Also Bought
PATH
AMCR
BYND
BCS
ALB
SU
EQNR
PPG
TWST
HCA
FIGS
FNKO
WMS
ANGI
EPATHAMCRBYNDBCSALBSUEQNRPPGTWSTHCAFIGSFNKOWMSANGIE
PATH$18,9
+2,11%
AMCR$8,11
+3,71%
BYND$2,01
+2,03%
BCS$20,32
+1,96%
ALB$98,4
+1,97%
SU$41,2
+2,06%
EQNR$24,7
+2,40%
PPG$101,35
+1,76%
TWST$33,97
+6,52%
HCA$427,24
+2,00%
FIGS$7,11
+2,45%
FNKO$3,18
+1,92%
WMS$140,53
+2,00%
ANGI$14,93
+5,74%
E$36,11
+1,98%
PATH$18,9
+2,11%
AMCR$8,11
+3,71%
BYND$2,01
+2,03%
BCS$20,32
+1,96%
ALB$98,4
+1,97%
SU$41,2
+2,06%
EQNR$24,7
+2,40%
PPG$101,35
+1,76%
TWST$33,97
+6,52%
HCA$427,24
+2,00%
FIGS$7,11
+2,45%
FNKO$3,18
+1,92%
WMS$140,53
+2,00%
ANGI$14,93
+5,74%
E$36,11
+1,98%
